These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19740462)

  • 1. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).
    MacNeil J; Steenland NK; Shankar A; Ducatman A
    Environ Res; 2009 Nov; 109(8):997-1003. PubMed ID: 19740462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.
    Karnes C; Winquist A; Steenland K
    Environ Res; 2014 Jan; 128():78-83. PubMed ID: 24299613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
    Barry V; Darrow LA; Klein M; Winquist A; Steenland K
    Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.
    Post GB; Cohn PD; Cooper KR
    Environ Res; 2012 Jul; 116():93-117. PubMed ID: 22560884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.
    Steenland K; Tinker S; Frisbee S; Ducatman A; Vaccarino V
    Am J Epidemiol; 2009 Nov; 170(10):1268-78. PubMed ID: 19846564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951-2003).
    Paustenbach DJ; Panko JM; Scott PK; Unice KM
    J Toxicol Environ Health A; 2007 Jan; 70(1):28-57. PubMed ID: 17162497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
    Steenland K; Zhao L; Winquist A; Parks C
    Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant.
    Simpson C; Winquist A; Lally C; Steenland K
    Environ Res; 2013 Nov; 127():22-8. PubMed ID: 24199934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum selenium and diabetes in U.S. adults.
    Bleys J; Navas-Acien A; Guallar E
    Diabetes Care; 2007 Apr; 30(4):829-34. PubMed ID: 17392543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort mortality study of workers exposed to perfluorooctanoic acid.
    Steenland K; Woskie S
    Am J Epidemiol; 2012 Nov; 176(10):909-17. PubMed ID: 23079607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort.
    Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K
    Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses.
    Rosen MB; Thibodeaux JR; Wood CR; Zehr RD; Schmid JE; Lau C
    Toxicology; 2007 Sep; 239(1-2):15-33. PubMed ID: 17681415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico.
    Coronado-González JA; Del Razo LM; García-Vargas G; Sanmiguel-Salazar F; Escobedo-de la Peña J
    Environ Res; 2007 Jul; 104(3):383-9. PubMed ID: 17475235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fasting serum glucose level and gastric cancer risk in a nested case-control study].
    Jun JK; Gwack J; Park SK; Choi YH; Kim Y; Shin A; Chang SH; Shin HR; Yoo KY
    J Prev Med Public Health; 2006 Nov; 39(6):493-8. PubMed ID: 17168202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men.
    Gilliland FD; Mandel JS
    Am J Ind Med; 1996 May; 29(5):560-8. PubMed ID: 8732932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus).
    Wei Y; Liu Y; Wang J; Tao Y; Dai J
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):285-97. PubMed ID: 17976672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
    Winquist A; Steenland K
    Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of risk for general population exposure to perfluorooctanoate.
    Butenhoff JL; Gaylor DW; Moore JA; Olsen GW; Rodricks J; Mandel JH; Zobel LR
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):363-80. PubMed ID: 15135214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary observations on perfluorinated compounds in plasma samples (1977-2004) of young German adults from an area with perfluorooctanoate-contaminated drinking water.
    Wilhelm M; Hölzer J; Dobler L; Rauchfuss K; Midasch O; Kraft M; Angerer J; Wiesmüller G
    Int J Hyg Environ Health; 2009 Mar; 212(2):142-5. PubMed ID: 18550432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis.
    Ning G; Bi Y; Wang T; Xu M; Xu Y; Huang Y; Li M; Li X; Wang W; Chen Y; Wu Y; Hou J; Song A; Liu Y; Lai S
    Ann Intern Med; 2011 Sep; 155(6):368-74. PubMed ID: 21930854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.